메뉴 건너뛰기




Volumn 13, Issue 2, 2006, Pages 96-103

Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha

Author keywords

HBV DNA; Hepatitis B e antigen; Interferon; Predictive value

Indexed keywords

ALPHA INTERFERON; HEPATITIS B(E) ANTIGEN; PEGINTERFERON; VIRUS DNA;

EID: 33645109452     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00661.x     Document Type: Article
Times cited : (27)

References (17)
  • 1
    • 0037366464 scopus 로고    scopus 로고
    • Asian-Pacific consensus statement on the management of chronic hepatitis B: An update
    • Liaw YF Leung N Guan R Lau GK Merican I Asian-Pacific consensus statement on the management of chronic hepatitis B: an update J Gastroenterol Hepatol 2003 18 3 239 245
    • (2003) J Gastroenterol Hepatol , vol.18 , Issue.3 , pp. 239-245
    • Liaw, Y.F.1    Leung, N.2    Guan, R.3    Lau, G.K.4    Merican, I.5
  • 2
    • 0025347975 scopus 로고
    • A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. the Hepatitis Interventional Therapy Group
    • Perrillo RP Schiff ER Davis GL et al A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group N Engl J Med 1990 323 5 295 301
    • (1990) N Engl J Med , vol.323 , Issue.5 , pp. 295-301
    • Perrillo, R.P.1    Schiff, E.R.2    Davis, G.L.3    Al, E.4
  • 3
    • 0033037480 scopus 로고    scopus 로고
    • Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment. the European Concerted Action on Viral Hepatitis (EUROHEP)
    • Janssen HL Gerken G Carreno V et al Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP) Hepatology 1999 30 1 238 243
    • (1999) Hepatology , vol.30 , Issue.1 , pp. 238-243
    • Janssen, H.L.1    Gerken, G.2    Carreno, V.3    Al, E.4
  • 4
    • 0036896130 scopus 로고    scopus 로고
    • HBV genotype B is associated with better response to interferon therapy in HBeAg (+) chronic hepatitis than genotype C
    • Wai CT Chu CJ Hussain M Lok AS HBV genotype B is associated with better response to interferon therapy in HBeAg (+) chronic hepatitis than genotype C Hepatology 2002 36 6 1425 1430
    • (2002) Hepatology , vol.36 , Issue.6 , pp. 1425-1430
    • Wai, C.T.1    Chu, C.J.2    Hussain, M.3    Lok, A.S.4
  • 5
    • 0033890782 scopus 로고    scopus 로고
    • Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays
    • Pas SD Fries E De Man RA Osterhaus AD Niesters HG Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays J Clin Microbiol 2000 38 8 2897 2901
    • (2000) J Clin Microbiol , vol.38 , Issue.8 , pp. 2897-2901
    • Pas, S.D.1    Fries, E.2    De Man, R.A.3    Osterhaus, A.D.4    Niesters, H.G.5
  • 6
    • 0033816667 scopus 로고    scopus 로고
    • Interferon-alpha therapy in chronic hepatitis B: Early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy
    • Heijtink RA Janssen HL Hop WC Osterhaus AD Schalm SW Interferon-alpha therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy J Viral Hepat 2000 7 5 382 386
    • (2000) J Viral Hepat , vol.7 , Issue.5 , pp. 382-386
    • Heijtink, R.A.1    Janssen, H.L.2    Hop, W.C.3    Osterhaus, A.D.4    Schalm, S.W.5
  • 7
    • 0027486290 scopus 로고
    • Monitoring of antiviral therapy with quantitative evaluation of HBeAg: A comparison with HBV DNA testing
    • Perrillo R Mimms L Schechtman K Robbins D Campbell C Monitoring of antiviral therapy with quantitative evaluation of HBeAg: a comparison with HBV DNA testing Hepatology 1993 18 6 1306 1312
    • (1993) Hepatology , vol.18 , Issue.6 , pp. 1306-1312
    • Perrillo, R.1    Mimms, L.2    Schechtman, K.3    Robbins, D.4    Campbell, C.5
  • 8
    • 0032940812 scopus 로고    scopus 로고
    • Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT
    • Brouwer JT Hansen BE Niesters HG Schalm SW Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT J Hepatol 1999 30 2 192 198
    • (1999) J Hepatol , vol.30 , Issue.2 , pp. 192-198
    • Brouwer, J.T.1    Hansen, B.E.2    Niesters, H.G.3    Schalm, S.W.4
  • 9
    • 0037179698 scopus 로고    scopus 로고
    • Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
    • Fried MW Shiffman ML Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 2002 347 13 975 982
    • (2002) N Engl J Med , vol.347 , Issue.13 , pp. 975-982
    • Fried, M.W.1    Shiffman, M.L.2    Reddy, K.R.3
  • 10
    • 0036829649 scopus 로고    scopus 로고
    • Management of hepatitis C: 2002 - June 10-12, 2002
    • National Institutes of Health Consensus Development Conference Statement
    • National Institutes of Health Consensus Development Conference Statement Management of hepatitis C: 2002 - June 10-12, 2002 Hepatology 2002 36 5 Suppl. 1 3 20
    • (2002) Hepatology , vol.36 , Issue.5 SUPPL. 1 , pp. 3-20
  • 11
    • 0031419744 scopus 로고    scopus 로고
    • Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B
    • Heijtink RA Kruining J Honkoop P et al. Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B J Med Virol 1997 53 3 282 287
    • (1997) J Med Virol , vol.53 , Issue.3 , pp. 282-287
    • Heijtink, R.A.1    Kruining, J.2    Honkoop, P.3
  • 12
    • 0032922675 scopus 로고    scopus 로고
    • Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group
    • Heermann KH Gerlich WH Chudy M Schaefer S Thomssen R Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group J Clin Microbiol 1999 37 1 68 73
    • (1999) J Clin Microbiol , vol.37 , Issue.1 , pp. 68-73
    • Heermann, K.H.1    Gerlich, W.H.2    Chudy, M.3    Schaefer, S.4    Thomssen, R.5
  • 13
    • 0033971684 scopus 로고    scopus 로고
    • Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy
    • Stuyver L Van Geyt C De Gendt S et al Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy J Clin Microbiol 2000 38 2 702 707
    • (2000) J Clin Microbiol , vol.38 , Issue.2 , pp. 702-707
    • Stuyver, L.1    Van Geyt, C.2    De Gendt, S.3    Al, E.4
  • 14
    • 0035010523 scopus 로고    scopus 로고
    • Management of hepatitis b: 2000-summary of a workshop
    • Lok AS Heathcote EJ Hoofnagle JH Management of hepatitis b: 2000-summary of a workshop Gastroenterology 2001 120 7 1828 1853
    • (2001) Gastroenterology , vol.120 , Issue.7 , pp. 1828-1853
    • Lok, A.S.1    Heathcote, E.J.2    Hoofnagle, J.H.3
  • 15
    • 0023710206 scopus 로고
    • Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach
    • DeLong ER DeLong DM Clarke-Pearson DL Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 1988 44 3 837 845
    • (1988) Biometrics , vol.44 , Issue.3 , pp. 837-845
    • Delong, E.R.1    Delong, D.M.2    Clarke-Pearson, D.L.3
  • 16
    • 0037371186 scopus 로고    scopus 로고
    • Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: Relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase
    • van Nunen AB Hansen BE Suh DJ et al Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase Gut 2003 52 3 420 424
    • (2003) Gut , vol.52 , Issue.3 , pp. 420-424
    • Van Nunen, A.B.1    Hansen, B.E.2    Suh, D.J.3    Al, E.4
  • 17
    • 0031828962 scopus 로고    scopus 로고
    • Predictive value of aminotransferase and hepatitis B virus DNA levels on response to interferon therapy for chronic hepatitis B
    • Lok AS Ghany MG Watson G Ayola B Predictive value of aminotransferase and hepatitis B virus DNA levels on response to interferon therapy for chronic hepatitis B J Viral Hepat 1998 5 3 171 178
    • (1998) J Viral Hepat , vol.5 , Issue.3 , pp. 171-178
    • Lok, A.S.1    Ghany, M.G.2    Watson, G.3    Ayola, B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.